Plasma-Synthesised Polypyrrole Implants for Spinal Cord Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for spinal cord injuries lack effective methods to restore autonomic functions, reduce neuropathic pain, and promote functional recovery, as existing biomaterials and transplants often fail to facilitate significant nerve regeneration due to inflammatory reactions and poor adhesion of axons.

Innovation Solution

Plasma-synthesised pyrrole-derived polymers, such as polypyrrole copolymers with polyethylene glycol (PPy/PEG) and iodine-doped polypyrrole (PPy/I), are used as non-biodegradable implants to provide a conductive and supportive environment for nerve regeneration, reducing inflammatory responses and enhancing axonal growth.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional chemical or electrochemical polymerization methods are used to synthesize conductive polymers, then the polymers can be produced, but they interfere with nerve tissue and cause inflammatory reactions that hinder regeneration

Engineering Contradiction:
Improveneuroregeneration supportVSAvoidinflammatory reaction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the synthesis method from chemical/electrochemical to plasma polymerization, which operates under different physical parameters (plasma state, vacuum conditions) that avoid the harmful byproducts of traditional methods. This parameter change eliminates the inflammatory response while maintaining polymer conductivity and structural integrity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

Plasma polymerization occurs in a controlled inert atmosphere that prevents unwanted chemical reactions. The plasma environment allows for clean polymer deposition without the harsh chemicals that would otherwise cause tissue irritation and inflammation, creating a biocompatible interface with nerve tissue.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

2Duration of action of stationary object

If biodegradable polymers are used as implants, then they can be degraded and replaced by natural tissue, but they fail to provide sufficient long-term support for axonal regeneration

Engineering Contradiction:
Improveimplant support durationVSAvoidaxonal regeneration support
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent creates a composite material system combining plasma-synthesized conductive polymer with biocompatible matrices. This composite provides both the long-term structural support needed for axonal regeneration and the electrical conductivity necessary for nerve function, while maintaining biocompatibility without relying on biodegradation.

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If chemical polymerization methods are used, then polymers can be synthesized, but the chemical intermediaries and byproducts create a unfavorable environment for healing

Engineering Contradiction:
Improvepolymer synthesisVSAvoidchemical byproducts
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical synthesis mechanisms with a physical plasma-based synthesis mechanism. Instead of using chemical reagents and intermediaries, the plasma process uses ionized gas and energy to directly polymerize monomers on the implant surface, eliminating harmful chemical byproducts while maintaining manufacturing efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These polymers demonstrate significant motor recovery and integration with nerve tissue, reducing tissue destruction and inflammatory responses, with PPy/PEG showing 5 times greater recovery and PPy/I showing 10 times greater recovery compared to controls, indicating effective neuroprotection and neuroregeneration without adverse effects.

Implementation Method 1

Plasma-synthesised pyrrole-derived polymers, such as polypyrrole copolymers with polyethylene glycol (PPy/PEG) and iodine-doped polypyrrole (PPy/I)

Methodology Applied
Scientific EffectPlasma synthesis: Plasma

Implementation Method 2

provide a conductive and supportive environment for nerve regeneration

Methodology Applied
Scientific EffectElectrical conduction: Conduction (electrical)

Data Source

PatentEP2164078B1Use of plasma-synthesised pyrol-derived polymers for the neuroprotection and reconnection of the nervous system
Publication Date: 2013.11.20 UNIV AUTONOMA METROPOLITANA
  • EP2164078B1 patent drawingFigure 1A~1B
  • EP2164078B1 patent drawingFigure 2A~2B
  • EP2164078B1 patent drawingFigure 3

AI summary

The purpose of the present invention is to demonstrate that semiconducting and non-biodegradable implants made with polypyrrole and polyethylenglycol copolymers and iodine-doped and plasma-synthesised pyrrole polymers, have a neuroprotector effect and induce the reconnection of the spinal cord after an injury; this effect was proved in a model involving a complete section of the spinal cord in rats; the results o the functional evaluation demonstrated 5 times greater recovery in animals implanted with the polypyrrole-polyethylenglycol copolymer compared with the control group which only underwent a complete section of the spinal cord; in addition, the functional recovery of the group with iodine-doped polypyrrole was ten times greater compared to the control group; in the histological study various inflammatory and immune cells were identified at the injury site in the three experimental groups with and without implants and the integration of the polymers in the nervous tissue of the spinal cord was also observed; finally, no respiratory, renal or skin infections, adverse effects or rejection of the biomaterials were found in any of the animals.